BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22965469)

  • 1. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity.
    Ying X; Qian Y; Jiang Y; Jiang Z; Song Z; Zhao C
    Acta Diabetol; 2012 Dec; 49(6):465-72. PubMed ID: 22965469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the apolipoprotein b/apolipoprotein a-I ratio, metabolic syndrome components, total cholesterol, and low-density lipoprotein cholesterol with insulin resistance in the population of georgia.
    Makaridze Z; Giorgadze E; Asatiani K
    Int J Endocrinol; 2014; 2014():925650. PubMed ID: 24949011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between high-sensitivity C-reactive protein and ApoB, ApoB/ApoA1 ratio in general population of China.
    Xu W; Li R; Zhang S; Gong L; Wang Z; Ren W; Xia C; Li Q
    Endocrine; 2012 Aug; 42(1):132-8. PubMed ID: 22246850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Apolipoprotein (ApoB/ApoA-1) and Lipoprotein (Total Cholesterol/HDL) Ratios in Obese Adolescents.
    Alemzadeh R; Kichler J
    Metab Syndr Relat Disord; 2018 Feb; 16(1):40-45. PubMed ID: 29154726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.
    Du T; Yuan G; Zhang M; Zhou X; Sun X; Yu X
    Cardiovasc Diabetol; 2014 Oct; 13():146. PubMed ID: 25326814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population.
    Belfki H; Ben Ali S; Bougatef S; Ben Ahmed D; Haddad N; Jmal A; Abdennebi M; Ben Romdhane H
    Exp Mol Pathol; 2011 Oct; 91(2):622-5. PubMed ID: 21801720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of corpulence parameters and haemoglobin A1c on metabolic control in type 2 diabetic patients: comparison of apolipoprotein B/A-I ratio with fasting and postprandial conventional lipid ratios.
    Diaf M; Khaled BM; Sellam F
    Libyan J Med; 2015; 10(1):27400. PubMed ID: 25959906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
    Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
    Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B/apolipoprotein A-I ratio in relation to the metabolic syndrome, its components, total cholesterol and low-density lipoprotein cholesterol in the population of Georgia.
    Makaridze Z; Giorgadze E; Asatiani K
    Georgian Med News; 2014 Sep; (234):32-9. PubMed ID: 25341235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.
    Ruixing Y; Yiyang L; Meng L; Kela L; Xingjiang L; Lin Z; Wanying L; Jinzhen W; Dezhai Y; Weixiong L
    Lipids Health Dis; 2010 Aug; 9():86. PubMed ID: 20716347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia in diabetes: a population-based study in Bali.
    Suastika K; Semadi IMS; Dwipayana IMP; Saraswati MR; Gotera W; Budhiarta AAG; Matsumoto K; Kajiwara N; Taniguchi H
    Int J Gen Med; 2019; 12():313-321. PubMed ID: 31564954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.
    Parish S; Peto R; Palmer A; Clarke R; Lewington S; Offer A; Whitlock G; Clark S; Youngman L; Sleight P; Collins R;
    Eur Heart J; 2009 Sep; 30(17):2137-46. PubMed ID: 19520708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
    Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
    Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.
    Guan Y; Hou X; Tian P; Ren L; Tang Y; Song A; Zhao J; Gao L; Song G
    Front Endocrinol (Lausanne); 2021; 12():646185. PubMed ID: 33967959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
    Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
    J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
    Batista MC; Welty FK; Diffenderfer MR; Sarnak MJ; Schaefer EJ; Lamon-Fava S; Asztalos BF; Dolnikowski GG; Brousseau ME; Marsh JB
    Metabolism; 2004 Oct; 53(10):1255-61. PubMed ID: 15375779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
    Matthan NR; Welty FK; Barrett PH; Harausz C; Dolnikowski GG; Parks JS; Eckel RH; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1092-7. PubMed ID: 15087307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.